Johnb Henneman News Today

Appoints Joseph Capper and William Jellison to Board of DirectorsAnnounces New $40 Million Share Repurchase Program BEDFORD, Mass., May 28, 2024 -- Anika Therapeutics, Inc. , a global joint...

R1 RCM Inc. (NASDAQ:RCM – Get Free Report) traded down 7.3% during trading on Monday after Royal Bank of Canada lowered their price target on the stock from $22.00 to $19.00. Royal Bank of Canada currently has an outperform rating on the stock. R1 RCM traded as low as $10.62 and last traded at $10.69. […]

R1 RCM (NASDAQ:RCM – Get Free Report) had its price objective lowered by equities researchers at Royal Bank of Canada from $22.00 to $19.00 in a report issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the healthcare provider’s stock. Royal Bank of Canada’s target price would indicate a potential upside […]

Shares of R1 RCM Inc. (NASDAQ:RCM – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fifteen research firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12 […]

Shares of R1 RCM Inc. (NASDAQ:RCM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the sixteen research firms that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company. The average […]

R1 RCM (NASDAQ:RCM – Free Report) had its price target lowered by Evercore ISI from $21.00 to $20.00 in a report published on Wednesday, FlyOnTheWall reports. Several other research firms have also recently issued reports on RCM. Citigroup initiated coverage on R1 RCM in a report on Friday, September 22nd. They issued a buy rating […]

R1 RCM (NASDAQ:RCM – Free Report) had its price target decreased by Evercore ISI from $21.00 to $20.00 in a report released on Wednesday, FlyOnTheWall reports. Several other research firms have also commented on RCM. Guggenheim reaffirmed a buy rating and issued a $21.00 price target on shares of R1 RCM in a report on […]

EFG Asset Management North America Corp. trimmed its holdings in shares of R1 RCM Inc. (NASDAQ:RCM – Free Report) by 1.8% in the second quarter, HoldingsChannel.com reports. The fund owned 216,683 shares of the healthcare provider’s stock after selling 3,905 shares during the period. EFG Asset Management North America Corp.’s holdings in R1 RCM were […]

Royal Bank of Canada restated their outperform rating on shares of R1 RCM (NASDAQ:RCM – Free Report) in a report released on Friday, Benzinga reports. The brokerage currently has a $22.00 price objective on the healthcare provider’s stock. RCM has been the subject of a number of other research reports. Barclays increased their target price […]

Citigroup initiated coverage on shares of R1 RCM (NASDAQ:RCM – Free Report) in a report issued on Friday, MarketBeat.com reports. The firm issued a buy rating and a $20.00 price objective on the healthcare provider’s stock. RCM has been the subject of a number of other reports. Barclays raised their price objective on shares of […]